Shutterstock.com

A Philadelphia jury has awarded nearly $28 million to the plaintiffs in the first bellwether trial to take place in state court over the blood thinner Xarelto. The verdict comes after three straight losses for plaintiffs in federal court.

The jury handed up the verdict against Bayer and Janssen Pharmaceuticals late morning Tuesday, awarding plaintiff Lynn Hartman $1.8 million in compensatory damages and $26 million in punitive damages. The verdict came after nearly one month of trial before Philadelphia Court of Common Pleas Judge Michael Erdos.

Lead trial counsel for the plaintiffs, Gary Douglas of Douglas and London, said the verdict was “vindication.”